FLOW trial and GLP-1 cost rant

from Docs Who Lift · host Docs Who Lift

Drs. Karl and Spencer discuss the recent FLOW trial where semaglutide was found to be kidney protective. They also go off about the costs of these medicines and what to do (including compounding considerations). Click here to see the study Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Episode metadata supplied by the publisher feed · Published Jun 4, 2024

Embed this episode

Attribution link and audio player

What this episode covers

Distinct summary based on available episode metadata or transcript content.

NOW PLAYING

FLOW trial and GLP-1 cost rant

0:00 45:30

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Docs Who Lift?

This episode is 45 minutes long.

When was this Docs Who Lift episode published?

This episode was published on June 4, 2024.

Can I download this Docs Who Lift episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!